Complication subgroup analysis of the RAAS system in T2DM patients. حسب Ningning Wang (560944)

الموضوعات:

Flow diagram of patient selection and subgroup classification. حسب Ningning Wang (560944)

الموضوعات:

The values of angiotensin II حسب Ningning Wang (560944)

الموضوعات:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups. حسب Ningning Wang (560944)

الموضوعات:

General characterization of T2DM patients and healthy controls. حسب Ningning Wang (560944)

الموضوعات:

Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. حسب Ningning Wang (560944)

الموضوعات:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different normotension subgroups. حسب Ningning Wang (560944)

الموضوعات:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes in hypertensive (A) and normotensive (B) patients. حسب Ningning Wang (560944)

الموضوعات:

Survey-weighted association of flavonoids and six subclasses intake with MASLD. حسب Yuwei He (1565941)

الموضوعات:

Survey-weighted baseline characteristic of the study population by MASLD. حسب Yuwei He (1565941)

الموضوعات:

Weighted Quantile Sum model regression index weights for the MASLD. حسب Yuwei He (1565941)

الموضوعات:

Association between flavonoid intakes and metabolic dysfunction-associated steatotic liver disease (MASLD) using a Restricted Cubic Spline regression model, adjusted for age, sex,... حسب Yuwei He (1565941)

الموضوعات:

The flowchart of the sample selection from NHANES 2007-2010, 2017-2018. حسب Yuwei He (1565941)

الموضوعات:

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. حسب Peiqi Yin (6533747)

Fig 5 - حسب Torsten Schober (20485754)

Fig 4 - حسب Torsten Schober (20485754)

Fig 6 - حسب Torsten Schober (20485754)

Fig 9 - حسب Torsten Schober (20485754)

Fig 8 - حسب Torsten Schober (20485754)

Table 2_The hemoglobin, albumin, lymphocyte, and platelet score as a useful predictor for mortality in older patients with hip fracture.docx حسب Zhicong Wang (810566)

"…For each unit increase in the HALP score, there was a significant decrease in 90-day mortality by 1.1% and in overall mortality by 1.0% (all p < 0.05). …"